Dermata Therapeutics Inc. Warrant (DRMAW) at a glance

Dermata Therapeutics Inc. Warrant (DRMAW) is a Healthcare company. It trades at $0.01, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Momentum (13/100). It is a relatively defensive holding with below-market volatility.

Price
$0.01
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
0.69
52-week range
$0.01 to $0.03
Vestovix Score54/ 100How this works
Value
58
Growth
50
Income
40
Safety
90
Momentum
13